Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abatement, acid, aged, appointment, August, benchmark, burden, capsid, characterized, clearance, Data, dedicated, delivery, ease, endpoint, Facilitation, gene, harnessing, human, infusion, IP, larger, leveraging, low, marker, medicine, MMUT, month, motion, moved, mutase, NaN, native, neutralizing, passage, pharmacodynamic, pioneering, potent, prescribed, primary, prophylactic, reach, recombination, reform, regimen, returned, RSU, serum, shown, steroid, SUNRISE, therapy, tolerability, transduction, transgene
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view